Renoprotective effects of dulaglutide in patients with T2DM and CKD
Sign Up to like & getrecommendations! Published in 2018 at "Nature Reviews Nephrology"
DOI: 10.1038/s41581-018-0055-x
Abstract: The AWARD-7 trial shows that the glucagon-like peptide 1 (GLP1) receptor agonist dulaglutide, which is not cleared by the kidney, seems to be renoprotective, ameliorates albuminuria and slows estimated glomerular filtration rate decline in patients… read more here.
Keywords: effects dulaglutide; renoprotective effects; t2dm ckd; patients t2dm ... See more keywords